Shalabi, D., Sethi, M., Okon, L., Debes, G. F., Lee, J. B., & Nikbakht, N. (2019). Lymphoplasmacellular mucositis ameliorated by α4β7 integrin inhibitor vedolizumab in a patient with ulcerative colitis. JAAD Case Rep.
Style de citation ChicagoShalabi, Doaa, Mansha Sethi, Lauren Okon, Gudrun F. Debes, Jason B. Lee, et Neda Nikbakht. "Lymphoplasmacellular Mucositis Ameliorated By α4β7 Integrin Inhibitor Vedolizumab in a Patient With Ulcerative Colitis." JAAD Case Rep 2019.
Style de citation MLAShalabi, Doaa, et al. "Lymphoplasmacellular Mucositis Ameliorated By α4β7 Integrin Inhibitor Vedolizumab in a Patient With Ulcerative Colitis." JAAD Case Rep 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.